Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Mozobil for Autologous Hematopoietic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE2
Quantitative and Qualitative Monocytes Analysis and Their Impact on CART Cells Reponse in Multiple Myeloma
- Status
- RECRUITING
- Phase
- N/A
A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in Subjects With Malignant Plasma Cell Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Study on the Safety and Efficacy of BCMA-CART±ASCT in Treating Young Multiple Myeloma Patients
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Pneumococcal Conjugated Vaccine 13 (PCV13) for Patients With Multiple Myeloma (MM)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat, Lenalidomide, and Dexamethasone in Participants With RRMM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel
- Status
- RECRUITING
- Phase
- PHASE2
GMMG Multiple Myeloma Registry
- Status
- RECRUITING
- Phase
- N/A
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS)
- Status
- RECRUITING
- Phase
- NA
Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial
- Status
- RECRUITING
- Phase
- PHASE4
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study of GR1803 Injection in Combination With Anti-CD38 Monoclonal Antibody for the Treatment of Participants With Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat in Participants With RRMM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
- Status
- RECRUITING
- Phase
- PHASE1
Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2